Physician

Alejandra Carolina Vivas, M.D.

According to 2025 Medicare claims, Alejandra Vivas, M.D. (NPI: 1033551163) practices dermatology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is VITALMD GROUP HOLDING LLC (NPI: 1871572032; TIN: 542129332) and primary practice location at 33021-3543. Vivas is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Vivas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 159 traditional Medicare patients, billed 871 HCPCS/CPT codes, and received $40,129 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,073 prescription claims across 372 beneficiaries totaling $395,564 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 95 records totaling $1,941. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,732 to $395,564. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$29K$59K2016 Medicare payment: $1,652 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $29,483 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $46,474 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $51,305 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $58,641 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $40,702 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $42,822 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $39,358 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $40,129 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20161225$1,652
2017103466$29,483
2018176913$46,474
20191891,008$51,305
20202121,103$58,641
2021146719$40,702
2022166780$42,822
2023150782$39,358
2024159871$40,129

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$198K$396K2015 Drug cost: $1,732 (USD; Tot_Drug_Cst)2016 Drug cost: $19,172 (USD; Tot_Drug_Cst)2017 Drug cost: $10,255 (USD; Tot_Drug_Cst)2018 Drug cost: $92,273 (USD; Tot_Drug_Cst)2019 Drug cost: $166,216 (USD; Tot_Drug_Cst)2020 Drug cost: $236,111 (USD; Tot_Drug_Cst)2021 Drug cost: $159,138 (USD; Tot_Drug_Cst)2022 Drug cost: $89,886 (USD; Tot_Drug_Cst)2023 Drug cost: $129,381 (USD; Tot_Drug_Cst)2024 Drug cost: $395,564 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R31$1,732
20163755$19,172
2017104228$10,255
2018168510$92,273
2019193476$166,216
2020182475$236,111
2021150409$159,138
2022267683$89,886
2023341953$129,381
20243721,073$395,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths4045$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more120188$63
11102Biopsy of related skin growth, first growth4956$61
17000Destruction of precancer skin growth, 1 growth5678$39
17003Destruction of precancer skin growth, 2-14 growths48343$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab12336$43,933
Clobetasol PropionateClobetasol Propionate1103,163$5,123
TretinoinTretinoin341,335$2,821
KetoconazoleKetoconazole1464,051$1,861
Triamcinolone AcetonideTriamcinolone Acetonide1815,017$1,322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.95$1,941ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alejandra Carolina Vivas, M.D.?

Tedicare shows public-source Medicare data for Alejandra Carolina Vivas, M.D. (NPI 1033551163), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandra Carolina Vivas, M.D. have ACO affiliation data?

Alejandra Carolina Vivas, M.D. is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Alejandra Carolina Vivas, M.D.?

Alejandra Carolina Vivas, M.D. is linked to VITALMD GROUP HOLDING LLC (billing NPI 1871572032) in the available physician profile data.

Does Alejandra Carolina Vivas, M.D. have Open Payments data?

Alejandra Carolina Vivas, M.D. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.